Stay updated with breaking news from Allurion Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Combination therapy led to nearly 19% weight loss at approximately 8 months Allurion, a company dedicated to ending obesity, today announced results from a new study that will be presented at the
Allurion has developed a small capsule that fills with water to create a gastric balloon after it settles in the stomach, offering a weight-loss alternative.
A combination of a swallowable Allurion gastric balloon and liraglutide delivers higher weight loss (around 19% after mean 4 months) than use of separate treatments.
Italy: An international multi-centre study has shown that combining the swallowable gastric balloon and the anti-obesity drug liraglutide is a safe and effective way to boost weight loss. The study is...
Researchers discovered a new treatment for overweight and obesity that combines the world's first and only procedureless swallowable gastric balloon--which is placed without surgery, endoscopy, or anaesthesia and naturally passes out of the body after approximately 16 weeks and the commonly prescribed anti-obesity drug liraglutide is a safe and effective way to boost weight loss.